NYSE:PHR

Phreesia Competitors

$52.88
+0.32 (+0.61 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$50.10
Now: $52.88
$54.36
50-Day Range
$50.85
MA: $58.38
$73.07
52-Week Range
$18.00
Now: $52.88
$81.59
Volume894,333 shs
Average Volume501,827 shs
Market Capitalization$2.37 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.42

Competitors

Phreesia (NYSE:PHR) Vs. NLSN, FOUR, CNXC, FVRR, RBA, and CDK

Should you be buying PHR stock or one of its competitors? Companies in the industry of "business services, not elsewhere classified" are considered alternatives and competitors to Phreesia, including Nielsen (NLSN), Shift4 Payments (FOUR), Concentrix (CNXC), Fiverr International (FVRR), Ritchie Bros. Auctioneers (RBA), and CDK Global (CDK).

Phreesia (NYSE:PHR) and Nielsen (NYSE:NLSN) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability.

Profitability

This table compares Phreesia and Nielsen's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Phreesia-16.37%-16.07%-11.18%
Nielsen-2.38%22.28%3.45%

Insider and Institutional Ownership

75.4% of Phreesia shares are owned by institutional investors. 28.2% of Phreesia shares are owned by insiders. Comparatively, 0.4% of Nielsen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Phreesia and Nielsen's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Phreesia$124.78 million19.03$-20,290,000.00($4.50)-11.75
Nielsen$6.50 billion1.41$-415,000,000.00$1.6915.13

Phreesia has higher earnings, but lower revenue than Nielsen. Phreesia is trading at a lower price-to-earnings ratio than Nielsen, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Phreesia has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500. Comparatively, Nielsen has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings for Phreesia and Nielsen, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Phreesia021002.83
Nielsen03602.67

Phreesia currently has a consensus target price of $53.6429, suggesting a potential upside of 1.44%. Nielsen has a consensus target price of $24.00, suggesting a potential downside of 6.14%. Given Phreesia's stronger consensus rating and higher possible upside, analysts plainly believe Phreesia is more favorable than Nielsen.

Summary

Phreesia beats Nielsen on 8 of the 14 factors compared between the two stocks.

Phreesia (NYSE:PHR) and Shift4 Payments (NYSE:FOUR) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Profitability

This table compares Phreesia and Shift4 Payments' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Phreesia-16.37%-16.07%-11.18%
Shift4 PaymentsN/AN/AN/A

Insider and Institutional Ownership

75.4% of Phreesia shares are held by institutional investors. Comparatively, 33.4% of Shift4 Payments shares are held by institutional investors. 28.2% of Phreesia shares are held by company insiders. Comparatively, 12.2% of Shift4 Payments shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Phreesia and Shift4 Payments' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Phreesia$124.78 million19.03$-20,290,000.00($4.50)-11.75
Shift4 PaymentsN/AN/AN/AN/AN/A

Shift4 Payments has lower revenue, but higher earnings than Phreesia.

Analyst Ratings

This is a breakdown of current ratings and target prices for Phreesia and Shift4 Payments, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Phreesia021002.83
Shift4 Payments04902.69

Phreesia currently has a consensus price target of $53.6429, suggesting a potential upside of 1.44%. Shift4 Payments has a consensus price target of $66.00, suggesting a potential downside of 34.91%. Given Phreesia's stronger consensus rating and higher possible upside, equities research analysts clearly believe Phreesia is more favorable than Shift4 Payments.

Summary

Phreesia beats Shift4 Payments on 6 of the 9 factors compared between the two stocks.

Phreesia (NYSE:PHR) and Concentrix (NASDAQ:CNXC) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Profitability

This table compares Phreesia and Concentrix's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Phreesia-16.37%-16.07%-11.18%
ConcentrixN/AN/AN/A

Insider and Institutional Ownership

75.4% of Phreesia shares are held by institutional investors. 28.2% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Phreesia and Concentrix's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Phreesia$124.78 million19.03$-20,290,000.00($4.50)-11.75
Concentrix$4.72 billion1.70$164.81 million$5.8926.15

Concentrix has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than Concentrix, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and target prices for Phreesia and Concentrix, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Phreesia021002.83
Concentrix00303.00

Phreesia currently has a consensus price target of $53.6429, suggesting a potential upside of 1.44%. Concentrix has a consensus price target of $122.50, suggesting a potential downside of 20.45%. Given Phreesia's higher possible upside, equities research analysts clearly believe Phreesia is more favorable than Concentrix.

Summary

Concentrix beats Phreesia on 8 of the 13 factors compared between the two stocks.

Phreesia (NYSE:PHR) and Fiverr International (NYSE:FVRR) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Profitability

This table compares Phreesia and Fiverr International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Phreesia-16.37%-16.07%-11.18%
Fiverr International-8.69%-4.48%-2.97%

Insider and Institutional Ownership

75.4% of Phreesia shares are held by institutional investors. Comparatively, 57.9% of Fiverr International shares are held by institutional investors. 28.2% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Phreesia and Fiverr International's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Phreesia$124.78 million19.03$-20,290,000.00($4.50)-11.75
Fiverr International$107.07 million65.61$-33,540,000.00($1.18)-192.08

Phreesia has higher revenue and earnings than Fiverr International. Fiverr International is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Phreesia has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500. Comparatively, Fiverr International has a beta of 2.24, suggesting that its share price is 124% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and target prices for Phreesia and Fiverr International, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Phreesia021002.83
Fiverr International13702.55

Phreesia currently has a consensus price target of $53.6429, suggesting a potential upside of 1.44%. Fiverr International has a consensus price target of $222.1667, suggesting a potential downside of 1.98%. Given Phreesia's stronger consensus rating and higher possible upside, equities research analysts clearly believe Phreesia is more favorable than Fiverr International.

Summary

Phreesia beats Fiverr International on 8 of the 14 factors compared between the two stocks.

Phreesia (NYSE:PHR) and Ritchie Bros. Auctioneers (NYSE:RBA) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Profitability

This table compares Phreesia and Ritchie Bros. Auctioneers' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Phreesia-16.37%-16.07%-11.18%
Ritchie Bros. Auctioneers13.03%19.76%7.55%

Insider and Institutional Ownership

75.4% of Phreesia shares are held by institutional investors. Comparatively, 80.3% of Ritchie Bros. Auctioneers shares are held by institutional investors. 28.2% of Phreesia shares are held by company insiders. Comparatively, 0.8% of Ritchie Bros. Auctioneers shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Phreesia and Ritchie Bros. Auctioneers' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Phreesia$124.78 million19.03$-20,290,000.00($4.50)-11.75
Ritchie Bros. Auctioneers$1.32 billion5.21$149.04 million$1.3346.94

Ritchie Bros. Auctioneers has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than Ritchie Bros. Auctioneers, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Phreesia has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500. Comparatively, Ritchie Bros. Auctioneers has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and target prices for Phreesia and Ritchie Bros. Auctioneers, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Phreesia021002.83
Ritchie Bros. Auctioneers14202.14

Phreesia currently has a consensus price target of $53.6429, suggesting a potential upside of 1.44%. Ritchie Bros. Auctioneers has a consensus price target of $58.9167, suggesting a potential downside of 5.63%. Given Phreesia's stronger consensus rating and higher possible upside, equities research analysts clearly believe Phreesia is more favorable than Ritchie Bros. Auctioneers.

Summary

Ritchie Bros. Auctioneers beats Phreesia on 8 of the 14 factors compared between the two stocks.

Phreesia (NYSE:PHR) and CDK Global (NASDAQ:CDK) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Profitability

This table compares Phreesia and CDK Global's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Phreesia-16.37%-16.07%-11.18%
CDK Global9.25%-62.84%12.62%

Insider and Institutional Ownership

75.4% of Phreesia shares are held by institutional investors. Comparatively, 82.2% of CDK Global shares are held by institutional investors. 28.2% of Phreesia shares are held by company insiders. Comparatively, 0.5% of CDK Global shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Phreesia and CDK Global's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Phreesia$124.78 million19.03$-20,290,000.00($4.50)-11.75
CDK Global$1.96 billion3.36$207.50 million$3.0517.72

CDK Global has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than CDK Global, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Phreesia has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500. Comparatively, CDK Global has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and target prices for Phreesia and CDK Global, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Phreesia021002.83
CDK Global00303.00

Phreesia currently has a consensus price target of $53.6429, suggesting a potential upside of 1.44%. CDK Global has a consensus price target of $64.75, suggesting a potential upside of 19.80%. Given CDK Global's stronger consensus rating and higher possible upside, analysts clearly believe CDK Global is more favorable than Phreesia.

Summary

CDK Global beats Phreesia on 9 of the 14 factors compared between the two stocks.


Phreesia Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Nielsen logo
NLSN
Nielsen
1.1$25.57+0.1%$9.15 billion$6.50 billion-60.88
Shift4 Payments logo
FOUR
Shift4 Payments
0.9$101.40+1.2%$8.17 billionN/A0.00
CNXC
Concentrix
1.7$154.00+0.6%$8.01 billion$4.72 billion26.15
Fiverr International logo
FVRR
Fiverr International
1.2$226.65+1.1%$7.03 billion$107.07 million-527.08
Ritchie Bros. Auctioneers logo
RBA
Ritchie Bros. Auctioneers
1.8$62.43+1.4%$6.86 billion$1.32 billion39.51Analyst Revision
News Coverage
CDK Global logo
CDK
CDK Global
2.0$54.05+0.3%$6.58 billion$1.96 billion36.52
Grubhub logo
GRUB
Grubhub
1.2$65.53+0.2%$6.11 billion$1.31 billion-52.42Insider Selling
Maximus logo
MMS
Maximus
2.0$94.07+0.9%$5.78 billion$3.46 billion27.67
HealthEquity logo
HQY
HealthEquity
1.8$69.33+2.6%$5.76 billion$531.99 million1,386.88Analyst Revision
Alliance Data Systems logo
ADS
Alliance Data Systems
2.6$109.81+1.7%$5.46 billion$5.58 billion15.75Analyst Report
TriNet Group logo
TNET
TriNet Group
1.5$81.16+1.8%$5.36 billion$3.86 billion18.70News Coverage
MPLN
MultiPlan
1.2$6.25+0.3%$4.18 billionN/A0.00Analyst Report
Analyst Revision
American Well logo
AMWL
American Well
1.4$17.14+1.6%$4.08 billionN/A0.00Insider Selling
Envestnet logo
ENV
Envestnet
1.2$74.70+0.5%$4.04 billion$900.13 million-574.62Analyst Report
Analyst Revision
News Coverage
Stamps.com logo
STMP
Stamps.com
1.7$205.64+0.5%$3.78 billion$571.85 million25.48
WNS logo
WNS
WNS
1.8$72.40+0.5%$3.60 billion$928.30 million35.84
HMS logo
HMSY
HMS
1.4$36.98+0.0%$3.28 billion$626.40 million60.61
ExlService logo
EXLS
ExlService
1.3$92.81+0.6%$3.11 billion$991.35 million40.89
Accolade logo
ACCD
Accolade
1.5$47.18+0.8%$2.62 billionN/A0.00Analyst Report
EVO Payments logo
EVOP
EVO Payments
1.4$28.37+0.2%$2.35 billion$485.78 million-105.07
NIC logo
EGOV
NIC
1.6$33.98+0.1%$2.28 billion$354.20 million37.76
Repay logo
RPAY
Repay
1.5$24.22+1.1%$2.13 billion$104.60 million-71.23Insider Selling
TechTarget logo
TTGT
TechTarget
1.5$72.58+2.2%$2.04 billion$133.96 million115.21Analyst Report
CBIZ logo
CBZ
CBIZ
1.3$33.62+0.9%$1.80 billion$948.42 million24.19
Cardtronics logo
CATM
Cardtronics
1.1$38.82+0.1%$1.75 billion$1.35 billion77.64
B. Riley Financial logo
RILY
B. Riley Financial
1.1$61.41+2.3%$1.67 billion$652.11 million38.87
Conduent logo
CNDT
Conduent
1.1$6.73+1.0%$1.43 billion$4.47 billion-2.05
Radware logo
RDWR
Radware
1.7$26.71+0.4%$1.25 billion$252.07 million92.10
GreenSky logo
GSKY
GreenSky
1.3$6.20+1.5%$1.13 billion$529.65 million124.02
QuinStreet logo
QNST
QuinStreet
2.0$20.16+0.7%$1.07 billion$490.34 million34.17
Tabula Rasa HealthCare logo
TRHC
Tabula Rasa HealthCare
1.3$43.16+0.1%$1.07 billion$284.71 million-16.23
i3 Verticals logo
IIIV
i3 Verticals
1.7$32.47+1.1%$1.04 billion$150.13 million-811.75Analyst Upgrade
Gravity logo
GRVY
Gravity
0.7$127.88+4.6%$888.64 million$307.18 million22.05
Viad logo
VVI
Viad
1.1$41.18+0.5%$843.28 million$1.37 billion-4.33
OptimizeRx logo
OPRX
OptimizeRx
1.5$49.35+0.7%$829.43 million$24.60 million-129.87
Advantage Solutions logo
ADV
Advantage Solutions
1.7$12.89+0.4%$728.29 millionN/A0.00News Coverage
Ideanomics logo
IDEX
Ideanomics
0.5$2.95+3.7%$704.96 million$44.57 million-2.50
Rimini Street logo
RMNI
Rimini Street
1.7$9.03+1.1%$694.50 million$281.05 million-34.73
Qiwi logo
QIWI
Qiwi
1.7$10.64+0.9%$667.27 million$635.40 million6.95
Liquidity Services logo
LQDT
Liquidity Services
1.3$18.87+1.0%$659.00 million$205.94 million-171.55Analyst Downgrade
Cass Information Systems logo
CASS
Cass Information Systems
0.9$45.64+0.5%$657.08 million$157.24 million26.53
Newtek Business Services logo
NEWT
Newtek Business Services
1.4$27.55+0.0%$617.12 million$59.29 million18.49Analyst Downgrade
International Money Express logo
IMXI
International Money Express
2.0$14.97+1.6%$572.12 million$319.60 million19.19Analyst Upgrade
MoneyGram International logo
MGI
MoneyGram International
1.4$6.49+2.5%$503.48 million$1.29 billion-17.08
Priority Technology logo
PRTH
Priority Technology
1.7$7.10+0.8%$480.23 million$371.85 million25.36
RGP
Resources Connection
1.7$14.29+1.9%$464.54 million$703.35 million37.61Earnings Announcement
News Coverage
Limelight Networks logo
LLNW
Limelight Networks
1.8$3.58+0.8%$444.40 million$200.63 million-59.67
UXIN
Uxin
0.5$1.40+2.9%$414.25 million$227.64 million-0.81
Digital Media Solutions logo
DMS
Digital Media Solutions
1.3$12.28+0.9%$397.79 millionN/A0.00Analyst Report
Emerald logo
EEX
Emerald
0.7$5.49+4.4%$396.78 million$360.90 million-0.60
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.